Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Volpara Health Technologies Company

VHT.AX
NZVHTE0001S6
A2DVK1

Price

1.24
Today +/-
+0
Today %
+0 %
P

Volpara Health Technologies stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Volpara Health Technologies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Volpara Health Technologies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Volpara Health Technologies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Volpara Health Technologies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Volpara Health Technologies Stock Price History

DateVolpara Health Technologies Price
5/22/20241.24 undefined
5/21/20241.24 undefined

Volpara Health Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Volpara Health Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Volpara Health Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Volpara Health Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Volpara Health Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Volpara Health Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Volpara Health Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Volpara Health Technologies’s growth potential.

Volpara Health Technologies Revenue, EBIT and net profit per share

DateVolpara Health Technologies RevenueVolpara Health Technologies EBITVolpara Health Technologies Net Income
2027e58.2 M undefined17.87 M undefined2.31 M undefined
2026e53.15 M undefined-3.16 M undefined-1.03 M undefined
2025e45.05 M undefined-6.8 M undefined-3.6 M undefined
2024e37.53 M undefined-10.34 M undefined-7.84 M undefined
202335.01 M undefined-13.37 M undefined-9.8 M undefined
202226.11 M undefined-16.76 M undefined-16.44 M undefined
202119.75 M undefined-19.24 M undefined-17.49 M undefined
202012.6 M undefined-24.09 M undefined-20.37 M undefined
20195 M undefined-12.28 M undefined-11.74 M undefined
20182.81 M undefined-9.07 M undefined-8.82 M undefined
20172.05 M undefined-9.5 M undefined-9.57 M undefined
20162.61 M undefined-4.01 M undefined-30.36 M undefined
20152.41 M undefined-2.31 M undefined-3.02 M undefined
20141.49 M undefined-2.22 M undefined-2.78 M undefined

Volpara Health Technologies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20142015201620172018201920202021202220232024e2025e2026e2027e
1222251219263537455358
-100.00---150.00140.0058.3336.8434.625.7121.6217.789.43
100.00100.0050.0050.00100.0080.0083.3394.7488.4691.43----
121124101823320000
-2-2-4-9-9-12-24-19-16-13-10-6-317
-200.00-100.00-200.00-450.00-450.00-240.00-200.00-100.00-61.54-37.14-27.03-13.33-5.6629.31
-2-3-30-9-8-11-20-17-16-9-7-3-12
-50.00900.00-70.00-11.1137.5081.82-15.00-5.88-43.75-22.22-57.14-66.67-300.00
126.02126.02126.02129.78146.04176.4210.14247.26251.38252.20000
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Volpara Health Technologies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Volpara Health Technologies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201520162017201820192020202120222023
                 
3.720.2812.884.8414.3831.3832.2318.1512.71
0.590.951.191.212.087.548.629.4710.54
0001330000390
00141432545300
00.2200.130.631.582.052.82.42
4.311.4514.086.3317.1240.5542.9530.4226.06
0.040.050.050.450.554.553.412.792.28
0000000359401
00764670000
000.030.070.3618.0127.1725.6625.04
000008.2219.2619.3321.59
0000.430.931.591.832.423.84
0.050.050.1511.8532.3751.6650.5553.15
4.361.514.247.3318.9772.9294.6180.9779.21
                 
0.50.7462.6463.1984.13140.08180.68181.49183.27
000000000
-10.56-40.67-49.92-58.53-69.83-89.24-106.3-121.96-131.36
-0.07-0.11-0.15-0.17-0.111.39-1.58-1.66-0.66
000000000
-10.13-40.0312.574.4914.1852.2272.857.8751.25
0.150.860.380.350.540.880.951.281.08
0.240.420.731.211.783.652.893.694.17
00.110.540.922.210.7711.4715.3620.64
000000000
040.1100.130.130.612.470.570.55
0.3941.491.642.614.6415.917.7820.9126.43
14.11000.210.133.162.91.911.53
000001.640.280.290
036191319085600
14.110.040.020.220.154.84.042.191.53
14.4941.531.662.834.7920.721.8223.127.96
4.361.514.247.3318.9772.9294.6180.9779.21
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Volpara Health Technologies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Volpara Health Technologies's financial health and stability.

Assets

Volpara Health Technologies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Volpara Health Technologies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Volpara Health Technologies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Volpara Health Technologies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
0000000-16-9
000000022
00000000-1
00001,00001,00000
0000000-2-2
000000000
000000000
-2-3-8-7-10-16-14-11-3
00000-10-2-2
00-119-9-39-23132
00-1110-8-38-22155
000000000
500000200
0022021584101
5021020554100
---1.00---3.00-1.00--
000000000
0-3-7-6-10-17-11-9-3
-2.37-3.45-8.31-7.87-11.34-17.65-14.85-13.53-6.42
000000000

Volpara Health Technologies stock margins

The Volpara Health Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Volpara Health Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Volpara Health Technologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Volpara Health Technologies's sales revenue. A higher gross margin percentage indicates that the Volpara Health Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Volpara Health Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Volpara Health Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Volpara Health Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Volpara Health Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Volpara Health Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Volpara Health Technologies Margin History

Volpara Health Technologies Gross marginVolpara Health Technologies Profit marginVolpara Health Technologies EBIT marginVolpara Health Technologies Profit margin
2027e92.45 %30.7 %3.97 %
2026e92.45 %-5.94 %-1.93 %
2025e92.45 %-15.1 %-7.98 %
2024e92.45 %-27.55 %-20.88 %
202392.45 %-38.2 %-27.99 %
202291.23 %-64.19 %-62.96 %
202191.43 %-97.41 %-88.56 %
202085.94 %-191.18 %-161.65 %
201982.56 %-245.54 %-234.82 %
201876.99 %-322.4 %-313.58 %
201766.78 %-463.85 %-467.56 %
201676.28 %-153.48 %-1,161.4 %
201584.56 %-95.89 %-125.45 %
201493.96 %-148.99 %-186.58 %

Volpara Health Technologies Stock Sales Revenue, EBIT, Earnings per Share

The Volpara Health Technologies earnings per share therefore indicates how much revenue Volpara Health Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Volpara Health Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Volpara Health Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Volpara Health Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Volpara Health Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Volpara Health Technologies Revenue, EBIT and net profit per share

DateVolpara Health Technologies Sales per ShareVolpara Health Technologies EBIT per shareVolpara Health Technologies Earnings per Share
2027e0.23 undefined0 undefined0.01 undefined
2026e0.21 undefined0 undefined-0 undefined
2025e0.18 undefined0 undefined-0.01 undefined
2024e0.15 undefined0 undefined-0.03 undefined
20230.14 undefined-0.05 undefined-0.04 undefined
20220.1 undefined-0.07 undefined-0.07 undefined
20210.08 undefined-0.08 undefined-0.07 undefined
20200.06 undefined-0.11 undefined-0.1 undefined
20190.03 undefined-0.07 undefined-0.07 undefined
20180.02 undefined-0.06 undefined-0.06 undefined
20170.02 undefined-0.07 undefined-0.07 undefined
20160.02 undefined-0.03 undefined-0.24 undefined
20150.02 undefined-0.02 undefined-0.02 undefined
20140.01 undefined-0.02 undefined-0.02 undefined

Volpara Health Technologies business model

Volpara Health Technologies Ltd is a medical technology company that specializes in offering products and services for breast cancer diagnosis and treatment. The company was founded in 2009 in New Zealand and has its headquarters in Wellington, as well as branches in the US, UK, and Australia. The business model of Volpara revolves around providing a cloud-based software platform called VolparaEnterprise, specifically developed for breast cancer diagnosis and treatment. This platform offers radiologists and radiological screening centers a complete range of tools to assess risks, make diagnoses, and plan treatments. It integrates automatic image analysis, artificial intelligence, and machine learning to enable more accurate and faster screenings. Volpara also assists in the interpretation of mammography images, particularly in assessing breast density, which is an important risk factor for the development of breast cancer. The company has developed a range of products, including VolparaDensity, VolparaLive! (formerly MRS), VolparaScore, and VolparaHealthchecks. Volpara has several divisions focusing on different aspects of breast cancer diagnosis and treatment: 1. VolparaClinical: This division is responsible for developing products for breast cancer diagnosis and assessment. These products include automated image analysis software and services for radiologists. 2. VolparaResearch: This division conducts clinical studies and research activities to expand knowledge and understanding of breast cancer. 3. VolparaEnterprise: This division offers a cloud-based software platform for radiological screening centers. The platform enables monitoring of image quality, risk assessment, disaster management, and continuing education for image screeners. 4. Volpara Solutions: This division is responsible for developing solutions for clinical decision support and patient management. The products offered by Volpara include VolparaDensity, an automated software for assessing women's breast density, VolparaLive!, an image analysis software for real-time monitoring of mammography image quality, VolparaScore, an automated software for assessing women's breast cancer risk, and VolparaHealthchecks, a set of tools for monitoring and treating breast cancer patients and assessing the risk for women with higher breast density. In conclusion, Volpara Health Technologies Ltd is a leading company in breast cancer diagnosis and treatment. The company aims to improve the efficiency and accuracy of mammography screenings and precise diagnosis of breast cancer. With a wide range of products and services, Volpara Health Technologies Ltd is on the right path to saving lives and winning the battle against breast cancer. Volpara Health Technologies is one of the most popular companies on Eulerpool.com.

Volpara Health Technologies SWOT Analysis

Strengths

Volpara Health Technologies Ltd leverages advanced technological solutions to provide cutting-edge breast imaging analytics and screening software. This technological advantage enables the company to offer accurate and efficient solutions to healthcare providers.

With an established market presence, Volpara Health Technologies Ltd has built a reputation as a trusted provider of breast imaging analytics solutions. The company has a solid customer base and a strong distribution network, allowing it to maintain a competitive edge.

Volpara Health Technologies Ltd offers a wide range of products and services tailored to meet the diverse needs of healthcare providers. Its comprehensive product portfolio includes breast density assessment, cancer risk stratification, and personalized patient care solutions, among others.

Volpara Health Technologies Ltd relies heavily on a few key customers for a significant portion of its revenue. Any loss of these key customers could have a detrimental impact on the company's financial performance and market position.

The pricing of Volpara Health Technologies Ltd's products and services is relatively high compared to some competitors in the market. This pricing strategy may limit the company's ability to attract price-sensitive customers, especially in price-sensitive markets.

As awareness of breast health and the importance of early detection continues to grow, there is a significant opportunity for Volpara Health Technologies Ltd to expand its customer base. The company can capitalize on this trend by marketing its innovative solutions to both healthcare providers and individual consumers.

The ongoing advancements in healthcare technology present a promising opportunity for Volpara Health Technologies Ltd to enhance its existing solutions and develop new offerings. By staying at the forefront of technological developments, the company can maintain its competitive advantage and capture new market segments.

The breast imaging analytics market is highly competitive, with the presence of several established players and new entrants. Volpara Health Technologies Ltd faces the risk of losing market share to competitors who may offer similar or more cost-effective solutions.

Volpara Health Technologies Ltd operates in a highly regulated healthcare industry. Compliance with various regulations and standards can pose challenges and create barriers to entry for new markets or regions. Non-compliance or changes in regulations may have negative consequences on the company's business operations.

Weaknesses

Volpara Health Technologies Ltd relies heavily on a few key customers for a significant portion of its revenue. Any loss of these key customers could have a detrimental impact on the company's financial performance and market position.

The pricing of Volpara Health Technologies Ltd's products and services is relatively high compared to some competitors in the market. This pricing strategy may limit the company's ability to attract price-sensitive customers, especially in price-sensitive markets.

As awareness of breast health and the importance of early detection continues to grow, there is a significant opportunity for Volpara Health Technologies Ltd to expand its customer base. The company can capitalize on this trend by marketing its innovative solutions to both healthcare providers and individual consumers.

The ongoing advancements in healthcare technology present a promising opportunity for Volpara Health Technologies Ltd to enhance its existing solutions and develop new offerings. By staying at the forefront of technological developments, the company can maintain its competitive advantage and capture new market segments.

The breast imaging analytics market is highly competitive, with the presence of several established players and new entrants. Volpara Health Technologies Ltd faces the risk of losing market share to competitors who may offer similar or more cost-effective solutions.

Volpara Health Technologies Ltd operates in a highly regulated healthcare industry. Compliance with various regulations and standards can pose challenges and create barriers to entry for new markets or regions. Non-compliance or changes in regulations may have negative consequences on the company's business operations.

Opportunities

As awareness of breast health and the importance of early detection continues to grow, there is a significant opportunity for Volpara Health Technologies Ltd to expand its customer base. The company can capitalize on this trend by marketing its innovative solutions to both healthcare providers and individual consumers.

The ongoing advancements in healthcare technology present a promising opportunity for Volpara Health Technologies Ltd to enhance its existing solutions and develop new offerings. By staying at the forefront of technological developments, the company can maintain its competitive advantage and capture new market segments.

The breast imaging analytics market is highly competitive, with the presence of several established players and new entrants. Volpara Health Technologies Ltd faces the risk of losing market share to competitors who may offer similar or more cost-effective solutions.

Volpara Health Technologies Ltd operates in a highly regulated healthcare industry. Compliance with various regulations and standards can pose challenges and create barriers to entry for new markets or regions. Non-compliance or changes in regulations may have negative consequences on the company's business operations.

Threats

The breast imaging analytics market is highly competitive, with the presence of several established players and new entrants. Volpara Health Technologies Ltd faces the risk of losing market share to competitors who may offer similar or more cost-effective solutions.

Volpara Health Technologies Ltd operates in a highly regulated healthcare industry. Compliance with various regulations and standards can pose challenges and create barriers to entry for new markets or regions. Non-compliance or changes in regulations may have negative consequences on the company's business operations.

Volpara Health Technologies Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Volpara Health Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Volpara Health Technologies shares outstanding

The number of shares was Volpara Health Technologies in 2023 — This indicates how many shares 252.202 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Volpara Health Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Volpara Health Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Volpara Health Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Volpara Health Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Volpara Health Technologies.

Volpara Health Technologies shareholders

%
Name
Stocks
Change
Date
7.26023 % Allen (Roger)18,467,84805/17/2023
6.37401 % Highnam (Ralph)16,213,56105/17/2023
2.84296 % Norges Bank Investment Management (NBIM)7,231,6471,293,38612/31/2023
2.60214 % Brady (John Michael)6,619,07505/17/2023
2.35106 % Sarner (Marcus)5,980,40405/17/2023
14.91055 % Harbour Asset Management Limited37,927,9632,334,4413/31/2023
1.18121 % Wood (Martin Francis)3,004,65505/17/2023
1.18121 % Wood (Kathleen Audrey)3,004,65405/17/2023
1.15465 % Wellington Management Company, LLP2,937,083-207,45512/31/2023
0.77308 % Yaffe (Martin)1,966,483-100,0005/17/2023
1
2
3

Volpara Health Technologies Executives and Management Board

Mr. Ralph Highnam
Volpara Health Technologies Chief Science and Innovation Officer (since 2022)
Compensation 664,966
Mr. Craig Hadfield
Volpara Health Technologies Chief Financial Officer, Joint Company Secretary
Compensation 514,382
Ms. Karin Lindgren
Volpara Health Technologies Non-Executive Independent Director
Compensation 206,863
Mr. John Pavlidis
Volpara Health Technologies Non-Executive Independent Director
Compensation 137,578
Mr. Paul Reid
Volpara Health Technologies Independent Chairman of the Board
Compensation 126,453
1
2
3

Volpara Health Technologies Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
FUJIFILM Holdings Stock
FUJIFILM Holdings
SupplierCustomer0,710,630,520,920,60-0,54
1

Most common questions regarding Volpara Health Technologies

What values and corporate philosophy does Volpara Health Technologies represent?

Volpara Health Technologies Ltd represents values of innovation, collaboration, and patient-centered care. As a leading provider of breast imaging analytics and technology, the company is dedicated to empowering healthcare providers with advanced solutions that improve early detection and treatment of breast cancer. Volpara's corporate philosophy is rooted in the belief that every woman should have access to personalized, high-quality breast care. By leveraging cutting-edge technology and a customer-centric approach, Volpara aims to reduce breast cancer mortality rates and enhance overall breast health. Volpara Health Technologies Ltd is committed to driving positive change in the healthcare industry through its values and dedication to improving patient outcomes.

In which countries and regions is Volpara Health Technologies primarily present?

Volpara Health Technologies Ltd is primarily present in countries such as the United States, Canada, Australia, New Zealand, Singapore, and the United Kingdom. These regions act as key markets for the company, where it focuses on providing advanced breast imaging analytics and solutions. Volpara's presence in these countries enables it to serve a wide range of healthcare providers and support breast cancer screening and early detection efforts globally.

What significant milestones has the company Volpara Health Technologies achieved?

Volpara Health Technologies Ltd has achieved significant milestones throughout its journey. Some notable accomplishments include expanding its global presence and customer base, launching cutting-edge products and services, and forging strategic partnerships with industry leaders. The company has consistently demonstrated its commitment to improving early detection and treatment outcomes for breast cancer, empowering healthcare providers with innovative solutions. Volpara Health Technologies Ltd has also made strides in research and development, continuously advancing its technology to enhance breast imaging and patient care. These milestones highlight the company's dedication to transforming the breast healthcare landscape and solidify its position as a leading player in the industry.

What is the history and background of the company Volpara Health Technologies?

Volpara Health Technologies Ltd is a leading medical technology company specializing in breast imaging analytics and analysis software. Founded in 2009, Volpara has emerged as a key player in the field, providing innovative solutions for early detection and personalized breast cancer screening. The company's proprietary software, VolparaDensity, accurately measures breast tissue density, a significant risk factor for breast cancer. Volpara's advanced technologies enable healthcare professionals to make informed decisions about breast health, resulting in earlier diagnoses and improved patient outcomes. With a strong commitment to revolutionizing breast cancer screening, Volpara Health Technologies Ltd continues to set new standards in the industry.

Who are the main competitors of Volpara Health Technologies in the market?

The main competitors of Volpara Health Technologies Ltd in the market include Hologic Inc., GE Healthcare, and iCAD Inc.

In which industries is Volpara Health Technologies primarily active?

Volpara Health Technologies Ltd primarily operates in the healthcare industry.

What is the business model of Volpara Health Technologies?

Volpara Health Technologies Ltd is an innovative healthcare company specializing in breast imaging analytics and software. As a leader in the field, Volpara aims to improve early detection of breast cancer through its advanced technology solutions. The company provides professional software and services that offer personalized assessments of breast density, image quality, and patient-specific risk. By empowering healthcare providers with accurate and objective data, Volpara is revolutionizing breast cancer screening and diagnosis. With its business model focused on delivering state-of-the-art solutions, Volpara Health Technologies Ltd strives to ensure better outcomes and enhanced patient care in the fight against breast cancer.

What is the P/E ratio of Volpara Health Technologies 2024?

The Volpara Health Technologies P/E ratio is -39.87.

What is the P/S ratio of Volpara Health Technologies 2024?

The Volpara Health Technologies P/S ratio is 8.33.

What is the Quality Investing of Volpara Health Technologies?

The Quality Investing for Volpara Health Technologies is 2/10.

What is the revenue of Volpara Health Technologies 2024?

The expected Volpara Health Technologies revenue is 37.53 M NZD.

How high is the profit of Volpara Health Technologies 2024?

The expected Volpara Health Technologies profit is -7.84 M NZD.

What is the business model of Volpara Health Technologies

Volpara Health Technologies specializes in diagnostic and medical imaging solutions for breast health. The company operates in various areas including software development, data analysis, medical imaging, and health provider information. Their main products include software solutions for breast cancer diagnosis, such as VolparaDensity for breast density analysis and VolparaEnterprise for preventive breast cancer diagnosis. Volpara also offers the VolparaLive service, which provides specialized medical support for breast health through remote monitoring. The company collaborates with healthcare professionals and organizations to improve patient care and aims to reduce cancer rates through better diagnostics and screening methods. Volpara's business model includes direct sales of software and services to hospitals, healthcare facilities, and clinics, as well as a partner program for healthcare industry companies. They offer their products and services globally and continuously improve their technology to meet the needs of patients and healthcare providers.

What is the Volpara Health Technologies dividend?

Volpara Health Technologies pays a dividend of 0 NZD distributed over payouts per year.

How often does Volpara Health Technologies pay dividends?

The dividend cannot currently be calculated for Volpara Health Technologies or the company does not pay out a dividend.

What is the Volpara Health Technologies ISIN?

The ISIN of Volpara Health Technologies is NZVHTE0001S6.

What is the Volpara Health Technologies WKN?

The WKN of Volpara Health Technologies is A2DVK1.

What is the Volpara Health Technologies ticker?

The ticker of Volpara Health Technologies is VHT.AX.

How much dividend does Volpara Health Technologies pay?

Over the past 12 months, Volpara Health Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Volpara Health Technologies is expected to pay a dividend of 0 NZD.

What is the dividend yield of Volpara Health Technologies?

The current dividend yield of Volpara Health Technologies is .

When does Volpara Health Technologies pay dividends?

Volpara Health Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Volpara Health Technologies?

Volpara Health Technologies paid dividends every year for the past 0 years.

What is the dividend of Volpara Health Technologies?

For the upcoming 12 months, dividends amounting to 0 NZD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Volpara Health Technologies located?

Volpara Health Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Volpara Health Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Volpara Health Technologies from 10/17/2024 amounting to 0 NZD, you needed to have the stock in your portfolio before the ex-date on 10/17/2024.

When did Volpara Health Technologies pay the last dividend?

The last dividend was paid out on 10/17/2024.

What was the dividend of Volpara Health Technologies in the year 2023?

In the year 2023, Volpara Health Technologies distributed 0 NZD as dividends.

In which currency does Volpara Health Technologies pay out the dividend?

The dividends of Volpara Health Technologies are distributed in NZD.

All fundamentals about Volpara Health Technologies

Our stock analysis for Volpara Health Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Volpara Health Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.